Status:
UNKNOWN
WORLD HEART FEDERATION (WHF) COVID-19 and Cardiovascular Disease Survey
Lead Sponsor:
Public Health Foundation of India
Collaborating Sponsors:
Centre for Chronic Disease Control, India
University of Cape Town
Conditions:
COVID-19
Cardiovascular Diseases
Eligibility:
All Genders
18+ years
Brief Summary
A global study for a better understanding of the cardiovascular conditions that increase the risk of developing severe COVID-19, and a better characterization of cardiovascular complications in hospit...
Detailed Description
COVID-19 may be cardiotropic in a subset of patients. Both acute and pre-existing CVD impact outcomes unfavorably. It is possible that one common CVD treatment, medications that impact ACE-2 function,...
Eligibility Criteria
Inclusion
- All adults (as locally defined) with confirmed COVID-19 infection who are hospitalized are eligible.
Exclusion
- Patients for whom investigators are unable to obtain informed consent will be excluded.
- Patients who are unlikely to stay in the recruiting centre for 30 days (i.e. likely to be transferred)
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
5200 Patients enrolled
Trial Details
Trial ID
NCT04475471
Start Date
September 1 2020
End Date
December 31 2023
Last Update
January 27 2023
Active Locations (32)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clinicas of the University
Buenos Aires, Argentina
2
Sanatorio Güemes Hospital
Buenos Aires, Argentina
3
Bangladesh Specialized Hospital (BSH)
Dhaka, Bangladesh
4
Dhaka Medical College Hospital (DMCH)
Dhaka, Bangladesh